Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

  • Bianca Weinstock-Guttman
  • , Steven L. Galetta
  • , Gavin Giovannoni
  • , Eva Havrdova
  • , Michael Hutchinson
  • , Ludwig Kappos
  • , Paul W. O'Connor
  • , J. Theodore Phillips
  • , Chris Polman
  • , William H. Stuart
  • , Frances Lynn
  • , Christophe Hotermans

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS'. Together they form a unique fingerprint.

Keyphrases

Neuroscience